Covid-19 Neurology News

Brain regions related to smell show decline following mild COVID-19

7 Mar 2022

Researchers from the University of Oxford have used data from UK Biobank participants to look at changes to the brain on average 4.5 months after mild SARS-CoV-2 infection.

WHO recommends antiviral drug for patients with non-severe covid-19 at highest risk of hospital admission

1 Mar 2022

The antiviral drug molnupiravir is conditionally recommended for patients with non-severe covid-19 who are at highest risk of hospitalisation, says a WHO Guideline Development Group of international experts in The BMJ today.

COVID-19’s Impact on the Brain Is a Key Topic of the 25th Biennial World Congress of Neurology

3 Oct 2021

The neurological impact of COVID-19, biomarkers for traumatic brain injury and migraine pathophysiology were among the many topics discussed at the XXV Biennial World Congress of Neurology on October 3 through 7, 2021, presented by the World Federation of Neurology.